2019 PAMA Survey
Under the Protecting Access to Medicare Act (PAMA) of 2014, Congress changed the way Medicare determines rates for the Clinical Laboratory Fee Schedule (CLFS). The implementation of PAMA resulted in significant cuts for a majority of the routine tests which physicians rely upon daily for diagnosis and treatment of patients. While the first year’s cut was limited to a maximum of 10%, the additional cuts will be phased-in over several years. Advocacy efforts are still underway to ensure that the cuts in the Clinical Laboratory Fee Schedule do not unduly harm patient access to laboratory testing.
Please take a minute to fill out the form below to convey your interest in this issue.
**Your responses will be included in the aggregate data and no information shared with us will be uniquely identifiable to any one respondent.